Aureole Pharmaceuticals Inc is categorized under Wholesale Pharmaceutical Products in Los Angeles, CA and active since 2002.
Aureole Pharmaceuticals Inc was established in 2002, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Wholesale Pharmaceutical Products business, which does work in the B2B market, and is classified as a Wholesale Pharmaceutical Products, under code number 424210 by the NAICS.
If you are seeking more information, feel free to contact Raffy Karamanoukian at the company’s single location by writing to 1245 Wellesley Avenue # 302, Los Angeles, California CA 90025 or by phoning (310) 770-2317. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Aureole Pharmaceuticals Inc |
Contact Person: | Raffy Karamanoukian |
Address: | 1245 Wellesley Avenue # 302, Los Angeles, California 90025 |
Phone Number: | (310) 770-2317 |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 2002 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Wholesale Pharmaceutical Products |
SIC Code: | 5122 |
NAICS Code: | 424210 |
Share This Business: |
Aureole Pharmaceuticals Inc was started in 2002 to provide professional Wholesale Pharmaceutical Products under the SIC code 5122 and NAICS code 424210. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Raffy Karamanoukian for inquiries that concern Aureole Pharmaceuticals Inc by calling the company number (310) 770-2317, as your correspondence is most welcome. Additionally, the physical location of the single location of Aureole Pharmaceuticals Inc can be found at the coordinates as well as the street address 1245 Wellesley Avenue # 302 in Los Angeles, California 90025.
For its online presence, you may visit Aureole Pharmaceuticals Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.